Newbridge Financial Services Group, Inc. Seelos Therapeutics, Inc. Transaction History

Newbridge Financial Services Group, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Oct 17, 2023	SELL	$0.16 - $1.64 $320 - $3,280	-2,000 Reduced 25.0%	6,000 $1,000
Q1 2021 Sep 07, 2021	BUY	$1.35 - $4.99 $10,800 - $39,920	8,000 New	8,000 $40,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $40.5M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.